142 related articles for article (PubMed ID: 7691442)
1. Ultrasensitive time-resolved immunofluorometric assay of prostate-specific antigen in serum and preliminary clinical studies.
Yu H; Diamandis EP
Clin Chem; 1993 Oct; 39(10):2108-14. PubMed ID: 7691442
[TBL] [Abstract][Full Text] [Related]
2. Double-label time-resolved immunofluorometric assay of prostate-specific antigen and of its complex with alpha 1-antichymotrypsin.
Leinonen J; Lövgren T; Vornanen T; Stenman UH
Clin Chem; 1993 Oct; 39(10):2098-103. PubMed ID: 7691441
[TBL] [Abstract][Full Text] [Related]
3. Ultrasensitive detection of prostate-specific antigen by a time-resolved immunofluorometric assay and the Immulite immunochemiluminescent third-generation assay: potential applications in prostate and breast cancers.
Ferguson RA; Yu H; Kalyvas M; Zammit S; Diamandis EP
Clin Chem; 1996 May; 42(5):675-84. PubMed ID: 8653891
[TBL] [Abstract][Full Text] [Related]
4. Early detection of residual prostate cancer after radical prostatectomy by an ultrasensitive assay for prostate specific antigen.
Stamey TA; Graves HC; Wehner N; Ferrari M; Freiha FS
J Urol; 1993 Apr; 149(4):787-92. PubMed ID: 7681119
[TBL] [Abstract][Full Text] [Related]
5. The use of 'ultrasensitive' prostate-specific antigen assays in the detection of biochemical recurrence after radical prostatectomy.
van Iersel MP; Thomas CM; Segers MF; Witjes WP; Debruyne FM; Oosterhof GO
Br J Urol; 1996 Mar; 77(3):418-22. PubMed ID: 8814849
[TBL] [Abstract][Full Text] [Related]
6. Ultrasensitive assay of prostate-specific antigen used for early detection of prostate cancer relapse and estimation of tumor-doubling time after radical prostatectomy.
Yu H; Diamandis EP; Prestigiacomo AF; Stamey TA
Clin Chem; 1995 Mar; 41(3):430-4. PubMed ID: 7533672
[TBL] [Abstract][Full Text] [Related]
7. Immunofluorometric assay for sensitive and specific measurement of human prostatic glandular kallikrein (hK2) in serum.
Piironen T; Lövgren J; Karp M; Eerola R; Lundwall A; Dowell B; Lövgren T; Lilja H; Pettersson K
Clin Chem; 1996 Jul; 42(7):1034-41. PubMed ID: 8674186
[TBL] [Abstract][Full Text] [Related]
8. Measurement of serum prostate specific antigen levels in women and in prostatectomized men with an ultrasensitive immunoassay technique.
Yu H; Diamandis EP
J Urol; 1995 Mar; 153(3 Pt 2):1004-8. PubMed ID: 7531781
[TBL] [Abstract][Full Text] [Related]
9. Early detection of recurrent prostate cancer with an ultrasensitive chemiluminescent prostate-specific antigen assay.
Ellis WJ; Vessella RL; Noteboom JL; Lange PH; Wolfert RL; Rittenhouse HG
Urology; 1997 Oct; 50(4):573-9. PubMed ID: 9338734
[TBL] [Abstract][Full Text] [Related]
10. Enzymatically amplified time-resolved fluorescence immunoassay with terbium chelates.
Christopoulos TK; Diamandis EP
Anal Chem; 1992 Feb; 64(4):342-6. PubMed ID: 1377456
[TBL] [Abstract][Full Text] [Related]
11. Detection of prostate cancer relapse with prostate specific antigen monitoring at levels of 0.001 to 0.1 microG./L.
Yu H; Diamandis EP; Wong PY; Nam R; Trachtenberg J
J Urol; 1997 Mar; 157(3):913-8. PubMed ID: 9072598
[TBL] [Abstract][Full Text] [Related]
12. Zeptomole detection sensitivity of prostate-specific antigen in a rapid microtitre plate assay using time-resolved fluorescence.
Härmä H; Soukka T; Lönnberg S; Paukkunen J; Tarkkinen P; Lövgren T
Luminescence; 2000; 15(6):351-5. PubMed ID: 11114110
[TBL] [Abstract][Full Text] [Related]
13. Methodological and clinical comparison of the ACS prostate-specific antigen assay and the Tandem-E prostate-specific antigen assay in prostate cancer.
Schambeck CM; Schmeller N; Stieber P; Jansen HM; Pahl H; Schneider W; Fateh-Moghadam A
Urology; 1995 Aug; 46(2):195-9. PubMed ID: 7542821
[TBL] [Abstract][Full Text] [Related]
14. Determination of fetal hemoglobin by time-resolved immunofluorometric assay.
Turpeinen U; Stenman UH
Clin Chem; 1992 Oct; 38(10):2013-8. PubMed ID: 1382895
[TBL] [Abstract][Full Text] [Related]
15. Ultrasensitive detection of prostate specific antigen in the followup of 422 patients after radical prostatectomy.
Haese A; Huland E; Graefen M; Hammerer P; Noldus J; Huland H
J Urol; 1999 Apr; 161(4):1206-11. PubMed ID: 10081870
[TBL] [Abstract][Full Text] [Related]
16. Usefulness of the nadir value of serum prostate-specific antigen measured by an ultrasensitive assay as a predictor of biochemical recurrence after radical prostatectomy for clinically localized prostate cancer.
Sakai I; Harada K; Kurahashi T; Muramaki M; Yamanaka K; Hara I; Inoue TA; Miyake H
Urol Int; 2006; 76(3):227-31. PubMed ID: 16601384
[TBL] [Abstract][Full Text] [Related]
17. Sensitive prostate specific antigen measurements identify men with long disease-free intervals and differentiate aggressive from indolent cancer recurrences within 2 years after radical prostatectomy.
Witherspoon LR; Lapeyrolerie T
J Urol; 1997 Apr; 157(4):1322-8. PubMed ID: 9120931
[TBL] [Abstract][Full Text] [Related]
18. Development of sensitive immunoassays for free and total human glandular kallikrein 2.
Väisänen V; Eriksson S; Ivaska KK; Lilja H; Nurmi M; Pettersson K
Clin Chem; 2004 Sep; 50(9):1607-17. PubMed ID: 15247158
[TBL] [Abstract][Full Text] [Related]
19. Dual-label time-resolved immunofluorometric assay of free and total prostate-specific antigen based on recombinant Fab fragments.
Eriksson S; Vehniäinen M; Jansén T; Meretoja V; Saviranta P; Pettersson K; Lövgren T
Clin Chem; 2000 May; 46(5):658-66. PubMed ID: 10794748
[TBL] [Abstract][Full Text] [Related]
20. Time-resolved immunofluorometric assay of human prostate-specific antigen.
Vihko P; Kurkela R; Ramberg J; Pelkonen I; Vihko R
Clin Chem; 1990 Jan; 36(1):92-5. PubMed ID: 1688748
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
